PMID- 30847392 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220408 IS - 2378-8038 (Print) IS - 2378-8038 (Electronic) IS - 2378-8038 (Linking) VI - 4 IP - 1 DP - 2019 Feb TI - Clinical application of molecular genetics in lymphatic malformations. PG - 170-173 LID - 10.1002/lio2.241 [doi] AB - OBJECTIVES: To describe the clinical presentation of lymphatic malformations (LM) and genotypically associated disorders and to summarize the recent literature regarding the genetic etiology of LM and provide a biologic correlation to medical and surgical management. RESULTS: LM are congenital lesions derived from a developmental abnormality of the lymphatic vessels. The severity of disease varies widely and complications can occur with higher staged disease and those associated with a known constellation of symptoms. Somatic mutations of the PIK3CA gene have been found to be an etiologic factor in the development of LM and associated overgrowth syndromes. Sirolimus is a mammalian target of rapamycin (mTOR) inhibitor that inhibits the pathway downstream of PIK3CA. Preliminary studies in select groups of patients suggest that sirolimus has a role in the medical management of certain aspects of this disease. CONCLUSIONS: Discovery of LM molecular genetics has led to the possibility of targeted therapies and highlights the importance of precision medicine in rare diseases. Identifying genetic mutations in larger cohorts of patients with LM will lead to additional insights. Knowledge of the genetic basis for disease can then lead to discovery of directed medical therapy. A specific molecular diagnosis can also help families understand better why their child is different and provide accurate counseling for subsequent pregnancies. LEVEL OF EVIDENCE: 6. FAU - Padia, Reema AU - Padia R AUID- ORCID: 0000-0002-5876-7816 AD - Division of Pediatric Otolaryngology Seattle Children's Hospital Seattle Washington. FAU - Zenner, Kaitlyn AU - Zenner K AD - Department of Otolaryngology-Head and Neck Surgery, Division of Genetic Medicine University of Washington School of Medicine Seattle Washington. FAU - Bly, Randall AU - Bly R AD - Division of Pediatric Otolaryngology Seattle Children's Hospital Seattle Washington. AD - Department of Otolaryngology-Head and Neck Surgery, Division of Genetic Medicine University of Washington School of Medicine Seattle Washington. FAU - Bennett, James AU - Bennett J AD - Department of Surgery, and the Center for Developmental Biology and Regenerative Medicine Seattle Children's Hospital Seattle Washington. AD - Department of Pediatrics Division of Genetic Medicine, University of Washington School of Medicine Seattle Washington. FAU - Bull, Catherine AU - Bull C AD - Division of Pediatric Otolaryngology Seattle Children's Hospital Seattle Washington. FAU - Perkins, Jonathan AU - Perkins J AUID- ORCID: 0000-0003-0181-3997 AD - Division of Pediatric Otolaryngology Seattle Children's Hospital Seattle Washington. AD - Department of Otolaryngology-Head and Neck Surgery, Division of Genetic Medicine University of Washington School of Medicine Seattle Washington. LA - eng PT - Journal Article PT - Review DEP - 20190112 PL - United States TA - Laryngoscope Investig Otolaryngol JT - Laryngoscope investigative otolaryngology JID - 101684963 PMC - PMC6383318 OTO - NOTNLM OT - Lymphatic malformation OT - activating mutation OT - bone OT - genetics OT - lymphocytopenia OT - molecular genetics OT - overgrowth syndrome OT - sirolimus OT - somatic mutation EDAT- 2019/03/09 06:00 MHDA- 2019/03/09 06:01 PMCR- 2019/01/12 CRDT- 2019/03/09 06:00 PHST- 2018/07/23 00:00 [received] PHST- 2018/10/12 00:00 [revised] PHST- 2018/11/08 00:00 [accepted] PHST- 2019/03/09 06:00 [entrez] PHST- 2019/03/09 06:00 [pubmed] PHST- 2019/03/09 06:01 [medline] PHST- 2019/01/12 00:00 [pmc-release] AID - LIO2241 [pii] AID - 10.1002/lio2.241 [doi] PST - epublish SO - Laryngoscope Investig Otolaryngol. 2019 Jan 12;4(1):170-173. doi: 10.1002/lio2.241. eCollection 2019 Feb.